The Next-Generation VWF/FVIII Concentrate, Wilate[R], Strives to Reflect the Normal Physiological Condition.
Business Wire › September 16, 2010
Linked as:
Extract
The Next-Generation VWF/FVIII Concentrate, Wilate[R], Strives to Reflect the Normal Physiological Condition.
World Haemophilia Experts Present Octapharma's Newest Product Specifically Developed for Patients with von Willebrand Disease
LACHEN, Switzerland -- At the recent World Federation of Haemophilia's (WFH's) world congress in Buenos Aires, Argentina, Octapharma AG confidently sponsored a symposium entitled "Modern Treatment Options for von Willebrand Disease (VWD) and Haemophilia B - What are the Benefits for the Patients?", which took place on July 12, 201...See the full content of this document
